Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
CNS Drugs|June 13, 2014
Presynaptic dopaminergic function: implications for understanding treatment response in psychosisI Bonoldi, O D HowesAdvances in Pharmacology (San Diego, Calif.)|September 24, 2013
The enduring centrality of dopamine in the pathophysiology of schizophrenia: in vivo evidence from the prodrome to the first psychotic episodeIlaria Bonoldi, O D HowesJournal of Psychopharmacology (Oxford, England)|September 11, 2004
Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapineO D Howes, L RifkinTranslational Psychiatry|February 8, 2017
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualizationO D Howes, R McCutcheonInternational Journal of Psychiatry in Clinical Practice|June 13, 2014
Manic psychosis induced by long term alpha-interferon treatment for hepatitis CO D Howes Kwame J McKenzieMolecular Psychiatry|October 4, 2017
The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disordersM Kokkinou, A H Ashok, O D HowesBMC Psychiatry|October 25, 2019
Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aidS J Kaar, C Gobjila, E Butler, et al.Current Pharmaceutical Design|January 14, 2012
From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairmentsO D Howes, P Fusar-Poli, M Bloomfield, et al.Translational Psychiatry|February 1, 2017
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic reviewT Dahoun, S V Trossbach, N J Brandon, et al.Current Pharmaceutical Design|August 20, 2009
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imagingO D Howes, A Egerton, V Allan, et al.Pageof 4